NewCardio Net Worth
NewCardio Net Worth Breakdown | NWCI |
NewCardio Net Worth Analysis
NewCardio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including NewCardio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of NewCardio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform NewCardio's net worth analysis. One common approach is to calculate NewCardio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares NewCardio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing NewCardio's net worth. This approach calculates the present value of NewCardio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of NewCardio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate NewCardio's net worth. This involves comparing NewCardio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into NewCardio's net worth relative to its peers.
Enterprise Value |
|
To determine if NewCardio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NewCardio's net worth research are outlined below:
NewCardio generated a negative expected return over the last 90 days | |
NewCardio has some characteristics of a very speculative penny stock | |
NewCardio currently holds 6.01 M in liabilities. NewCardio has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about NewCardio's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 257.4 K. Net Loss for the year was (11.5 M) with profit before overhead, payroll, taxes, and interest of 105.1 K. | |
NewCardio currently holds about 13.06 K in cash with (4.56 M) of positive cash flow from operations. | |
NewCardio has a frail financial position based on the latest SEC disclosures |
Follow NewCardio's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 49.72 K.Market Cap |
|
Project NewCardio's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.73) | (4.96) | |
Return On Capital Employed | 11.10 | 11.66 | |
Return On Assets | (4.63) | (4.87) | |
Return On Equity | 4.18 | 2.57 |
When accessing NewCardio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures NewCardio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of NewCardio's profitability and make more informed investment decisions.
Evaluate NewCardio's management efficiency
NewCardio has return on total asset (ROA) of (2.2419) % which means that it has lost $2.2419 on every $100 spent on assets. This is way below average. NewCardio's management efficiency ratios could be used to measure how well NewCardio manages its routine affairs as well as how well it operates its assets and liabilities. The NewCardio's current Return On Capital Employed is estimated to increase to 11.66, while Return On Tangible Assets are projected to decrease to (4.96). As of now, NewCardio's Intangible Assets are increasing as compared to previous years.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.10) | (0.10) | |
Tangible Book Value Per Share | (0.10) | (0.11) | |
Enterprise Value Over EBITDA | (3.28) | (3.11) | |
Price Book Value Ratio | (8.85) | (8.41) | |
Enterprise Value Multiple | (3.28) | (3.11) | |
Price Fair Value | (8.85) | (8.41) | |
Enterprise Value | 24.1 M | 15.6 M |
NewCardio showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 0.2084 | Revenue 238.6 K | Quarterly Revenue Growth (0.90) | Revenue Per Share 0.008 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NewCardio insiders, such as employees or executives, is commonly permitted as long as it does not rely on NewCardio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NewCardio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Farallon Capital Management Llc over a month ago Acquisition by Farallon Capital Management Llc of 445 shares of NewCardio at 0.01 subject to Rule 16b-3 | ||
Farallon Partners L L C/ca over two months ago Acquisition by Farallon Partners L L Cca of tradable shares of NewCardio at 0.01 subject to Rule 16b-3 | ||
Farallon Capital Management Llc over three months ago Acquisition by Farallon Capital Management Llc of tradable shares of NewCardio at 0.01 subject to Rule 16b-3 | ||
Farallon Partners L L C/ca over six months ago Acquisition by Farallon Partners L L Cca of tradable shares of NewCardio at 0.01 subject to Rule 16b-3 | ||
Farallon Partners L L C/ca over six months ago Acquisition by Farallon Partners L L Cca of 1012 shares of NewCardio at 0.01 subject to Rule 16b-3 | ||
Farallon Partners L L C/ca over six months ago Acquisition by Farallon Partners L L Cca of 1850 shares of NewCardio at 0.01 subject to Rule 16b-3 |
NewCardio Earnings per Share Projection vs Actual
When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewCardio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.008 | Quarterly Revenue Growth (0.90) | Return On Assets (2.24) |
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.